Orange Book product · Brand (NDA)
KLONOPIN
CLONAZEPAM
At a glance
Approved Prior to Jan 1, 1982
Approved
Brand (NDA)
Application
AB
TE code
None
Listed patents
Key dates
No patent or exclusivity dates are listed for this product.
Pharmaceutical detail
Active ingredient
CLONAZEPAM
Strength
0.5MG
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
NDA 017533
Product number
001
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 1997KLONOPIN RAPIDLY DISINTEGRATINGBrand (NDA)
NDA 020813 · ROCHE
- 2026CLONAZEPAMGeneric (ANDA)
ANDA 216988 · RUBICON RESEARCH
- 2019CLONAZEPAMGeneric (ANDA)
ANDA 211033 · ALEMBIC
- 2014CLONAZEPAMGeneric (ANDA)
ANDA 078654 · SUN PHARM INDS INC
- 2006CLONAZEPAMGeneric (ANDA)
ANDA 077856 · PRINSTON INC
- 2005CLONAZEPAMGeneric (ANDA)
ANDA 077194 · BARR
- 2005CLONAZEPAMGeneric (ANDA)
ANDA 077171 · PH HEALTH
- 2005CLONAZEPAMGeneric (ANDA)
ANDA 077147 · ACCORD HLTHCARE
- 2001CLONAZEPAMGeneric (ANDA)
ANDA 075423 · SUN PHARM INDS INC
- 2000CLONAZEPAMGeneric (ANDA)
ANDA 075468 · RUBICON RESEARCH
- 1998CLONAZEPAMGeneric (ANDA)
ANDA 075150 · AUROBINDO PHARMA USA
- 1998CLONAZEPAMGeneric (ANDA)
ANDA 074920 · TEVA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
